Many factors impact decisions regarding timing and mode of delivery in the
gestational diabetic patient at term. Delivery of a healthy, appropriately
sized infant is our goal, and we attempt to achieve this while minimizing m
aternal morbidity. This article evaluates the existing literature to define
valid indications for intervention at term; to assess the need for fetal l
ung maturity testing; to compare sonographic predictors of the overgrown fe
tus; and to determine the optimal delivery route for macrosomic fetuses. Ar
eas to be targeted for further investigation are also presented.